Terlipressin vs other vasoactive drugs
Mortality (all‐cause) · people with cirrhosis and hepatorenal syndrome
It is very uncertain whether terlipressin changes mortality (All‐cause) compared with other vasoactive drugs (very low certainty).
1 finding from 1 review
- Terlipressin versus other vasoactive drugs for hepatorenal syndrome 2017 · Cochrane Headline outcomes onlyRR 0.96 [0.88, 1.06]474 participantsVery low